The report provides a detailed analysis essential for establishing a Flavoxate production plant. It encompasses all critical aspects necessary for Flavoxate production, including the cost of Flavoxate production, Flavoxate plant cost, Flavoxate production costs, and the overall Flavoxate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Flavoxate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Flavoxate is a medication mainly used to relieve discomfort linked to urinary tract problems. It is widely used as a urinary antispasmodic agent to ease urinary discomfort caused by conditions that lead to bladder irritation or muscle spasms. It is commonly given to patients dealing with cystitis, urethritis, or post-surgical irritation, where controlling bladder spasms makes daily activities more manageable.
It also finds its application in treatment plans where reducing muscle tension in the urinary system supports better recovery and comfort, such as in patients dealing with irritation after urological procedures.
The primary factor that drives the demand for Flavoxate is its application as a medicine in managing symptoms linked to various urinary conditions, which largely boosts its market growth. Its usage as a smooth-muscle relaxant for managing urinary tract discomfort, including conditions such as cystitis, painful urination, and bladder spasms, also boosts its demand in the urology and pharmaceutical sectors.
Its involvement in easing symptoms linked to inflammation or irritation of the urinary tract, along with its supportive role after urological procedures, further increases its demand in the medical and healthcare sectors.
Additionally, industrial Flavoxate procurement is influenced by factors such as the cost and availability of active raw materials, compliance with regulatory and quality standards, and adherence to safety and environmental guidelines. Improvements in production technology, dependable supplier chains, sustainable practices, and efficient global distribution systems also shape its procurement decisions and help support the overall Flavoxate market.
Raw Material for Flavoxate Production
According to the Flavoxate production plant project report, the major raw materials for Flavoxate production include 2-Propionyloxybenzoic Acid-Anhydrous Aluminium Chloride-Carbon Disulfide.
Production Process of Flavoxate
The extensive Flavoxate production cost report consists of the following industrial production process:
- Production from 2-Hydroxy-3-carboxypropiophenone: The production process of Flavoxate begins with the preparation of 2-hydroxy-3-carboxypropiophenone by reacting 2-propionyloxybenzoic acid with anhydrous aluminium chloride in carbon disulfide, followed by heating. Then, the intermediate is condensed with sodium benzoate and benzoic anhydride at high temperature to form the flavone core. The mixture is further treated with potassium hydroxide to give 3-methylflavone-8-carboxylic acid. Further, the acid is converted to its acid chloride by refluxing with thionyl chloride in benzene and removing the solvent. The resulting 3-methylflavone-8-carboxylic acid chloride is then reacted with piperidinoethanol under reflux, which produces the corresponding ester. Finally, the obtained product is treated with hydrochloric acid, which forms piperidinoethyl 3-methylflavone-8-carboxylate hydrochloride or Flavoxate hydrochloride, as the desired product.
Flavoxate appears as a white to pale crystalline powder with no characteristic odour. The molecular formula of the compound is C24H25NO4, and its molar mass is 391.46 g/mol. The melting point of Flavoxate is around 232-234 degree Celsius. The pKa value of the compound is 7.3. It is practically insoluble in water but exhibits solubility in organic solvents. Its solubility in water is 10 mg/L (at 37 degree Celsius). It remains stable under normal storage conditions when protected from excessive moisture and heat. The compound should be handled with routine laboratory protection due to its pharmacological activity.